WHO also found patterns of increasing resistance to treatment in several bacteria-causing common infections in the community, based on data provided by 87 countries in 2020.
The findings are significant as the GLASS report provides, for the first time, analyses for antimicrobial resistance (AMR) rates in the context of national testing coverage, as well as AMR trends since 2017 and data on antimicrobial consumption in humans in 27 countries. In addition, the report includes an innovative interactive digital format to accommodate data extraction and graphics…